These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33361739)

  • 1. Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.
    Ling X; Zheng Z; Xu J; Xu G; Zhou H; Lin Z; Li Y; Liang J; Lu H
    Med Sci Monit; 2020 Dec; 26():e928826. PubMed ID: 33361739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Wang SC; Wu CH; Fu HC; Ou YC; Tsai CC; Chen YY; Wang YW; Hunag SW; Huang SY; Lan J; Lin H
    Int J Gynecol Pathol; 2024 Jul; 43(4):316-325. PubMed ID: 37732995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ovarian involvement in young and premenopausal endometrioid endometrial cancer patients.
    Li J; Zhu Q; Yang B; Ning C; Liu X; Luo X; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():151-154. PubMed ID: 29408747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative predictive factor analysis of ovarian malignant involvement in premenopausal patients with clinical stage I endometrioid endometrial carcinoma.
    Chen Q; Feng Y; Wang W; Lv W; Li B
    Sci Rep; 2021 Jan; 11(1):1219. PubMed ID: 33441576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between estrogen receptor status and clinicopathologic parameters in endometrial cancer: a comparative study by immunohistochemistry using different scoring systems].
    Wang Y; Ma XL; Xi CG; Lin J; Ren CX; Liu CR
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):509-14. PubMed ID: 24246914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival.
    Ignatov T; Eggemann H; Burger E; Ortmann O; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1103-1107. PubMed ID: 29541859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
    Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.
    van Weelden WJ; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F;
    Hum Pathol; 2021 Mar; 109():80-91. PubMed ID: 33338506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
    Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
    Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
    Karaferic A; Jovanovic D; Jelic S
    J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of parametrial spread in endometrial carcinoma.
    Watanabe Y; Satou T; Nakai H; Etoh T; Dote K; Fujinami N; Hoshiai H
    Obstet Gynecol; 2010 Nov; 116(5):1027-34. PubMed ID: 20966685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer].
    Gottwald L; Kubiak R; Pasz-Walczak G; Sek P; Piekarski J; Szwalski J; Spych M; Chałubińska-Fendler J; Suzin J; Tyliński W; Jeziorski A
    Ginekol Pol; 2013 Feb; 84(2):95-101. PubMed ID: 23668054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
    Li Q; Zhang X
    Int J Gynaecol Obstet; 2023 Apr; 161(1):144-150. PubMed ID: 36453189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.